Skip to main content

Articles

Page 1 of 4

  1. Social determinants of health (SDOH) research demonstrates poverty, access to healthcare, discrimination, and environmental factors influence health outcomes. Several models are commonly used to assess SDOH, y...

    Authors: Zach W. Cooper, Orion Mowbray and Leslie Johnson
    Citation: Clinical Diabetes and Endocrinology 2024 10:4
  2. Due to the progressive decline in β-cell function, it is often necessary to utilize multiple agents with complementary mechanisms of action to address various facets and achieve glycemic control. Thus, this st...

    Authors: Mondal Aashish, Naskar Arindam, Sheelu Shafiq Siddiqi, Deepak Bhosle, V. J. Mallikarjuna, Dange Amol, Sorate Sanket, Gavali Omkar, Patel Parth, Hasnani Dhruvi, Prasad Durga, Dalwadi Pradeep, Kumar Suresh, Pathak Vaishali, Chaudhari Mayura, Basu Indraneel…
    Citation: Clinical Diabetes and Endocrinology 2024 10:3
  3. Identification of modifiable risk factors for Alzheimer’s Disease (AD) onset is an important aspect of controlling the burden imposed by this disease on an increasing number of older U.S. adults. Graves diseas...

    Authors: Arseniy Pavlovich Yashkin, Stanislav Kolpakov, Svetlana Ukraintseva, Anatoliy Yashin and Igor Akushevich
    Citation: Clinical Diabetes and Endocrinology 2024 10:11
  4. Glucocorticoid (GC)-induced hyperglycemia is a frequent issue, however there are no specific guidelines for this diabetes subtype. Although treat-to-target insulin is recommended in general to correct hypergly...

    Authors: Tristan Struja, Neele Nitritz, Islay Alexander, Kevin Kupferschmid, Jason F. Hafner, Carlos C. Spagnuolo, Philipp Schuetz, Beat Mueller and Claudine A. Blum
    Citation: Clinical Diabetes and Endocrinology 2024 10:8
  5. Professional guidelines recommend an HbA1c < 7% for most people with diabetes and < 8.5% for those with relaxed glycemic goals. However, many people with type 2 diabetes mellitus (T2DM) are unable to achieve t...

    Authors: Judy Z. Louie, Dov Shiffman, Charles M. Rowland, Norma S. Kenyon, Ernesto Bernal-Mizrachi, Michael J. McPhaul and Rajesh Garg
    Citation: Clinical Diabetes and Endocrinology 2024 10:2
  6. The objective of this meta-analysis was to investigate the association between plasma bilirubin levels and the incidence of metabolic syndrome and diabetes mellitus across all populations.

    Authors: Maziar Nikouei, Mojtaba Cheraghi, Faezeh Ghaempanah, Parisa Kohneposhi, Nadia Saniee, Sirous Hemmatpour and Yousef Moradi
    Citation: Clinical Diabetes and Endocrinology 2024 10:1
  7. Obesity has reached epidemic proportions in children and adolescents in the United States. Children’s behaviors are strongly influenced by parental behaviors, and weight loss in parents is positively associate...

    Authors: Namratha Atluri, Joshua Thariath, Laura N. McEwen, Wen Ye, MinKyoung Song and William H. Herman
    Citation: Clinical Diabetes and Endocrinology 2023 9:8
  8. Homeostasis model assessment for insulin resistance (HOMA-IR) is a biomarker for type 2 diabetes mellitus (T2DM). However, the role of HOMA-IR in the non-diabetic is unclear. This study aimed to determine whet...

    Authors: Jibeom Lee, Moon-hyun Kim, Ji-Yong Jang and Chang-Myung Oh
    Citation: Clinical Diabetes and Endocrinology 2023 9:7
  9. Pituitary adenomas (PPAs) are uncommon in childhood and adolescence, accounting for 2–6% of all intracranial neoplasms. Delayed puberty, growth retardation, galactorrhea and weight gain are common features at ...

    Authors: Cristina Aguilar-Riera, María Clemente, Núria González-Llorens, Eduard Mogas, Ariadna Campos-Martorell, Anna Fàbregas, Betina Biagetti, Elida Vázquez and Diego Yeste
    Citation: Clinical Diabetes and Endocrinology 2023 9:5
  10. The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing among patients with type 1 diabetes (T1D) paralleling the increasing prevalence of obesity among this population. However, little is kn...

    Authors: Shaheen Tomah, Tareq Salah, Marwa Al-Badri, Shilton Dhaver, Hannah Gardner, Mhd Wael Tasabehji and Osama Hamdy
    Citation: Clinical Diabetes and Endocrinology 2023 9:3
  11. The risk of adverse outcomes in recurrent GDM pregnancy has not been well documented, particularly in women who have already had an adverse outcome. The aim of this study was to compare the risk of recurrent a...

    Authors: Sue Lynn Lau, Alex Chung, Joanna Kao, Susan Hendon, Wendy Hawke and Sue Mei Lau
    Citation: Clinical Diabetes and Endocrinology 2023 9:2
  12. Undiagnosed type 2 diabetes is common and can lead to unrecognized health complications. Given that earlier detection can reduce the damage to vital organs, it is important for all persons to be able to make t...

    Authors: María Teresa Muñoz Sastre, Paul Clay Sorum, Lonzozou Kpanake and Etienne Mullet
    Citation: Clinical Diabetes and Endocrinology 2023 9:1
  13. Genetic alterations and high levels of the vascular endothelial growth factor (VEGF) are presumptive risk factors for differentiated thyroid cancer (DTC).

    Authors: Mohamad Mohsen Motawea, Maysaa El Sayed Zaki, Maha Saif, Asmaa Osama BS Osman and Aml Mohamed Nada
    Citation: Clinical Diabetes and Endocrinology 2022 8:9
  14. Hypoglycemic syndrome is a potentially life-threatening condition that can lead to the disruption of brain and internal organ functions, and in severe cases to irreparable consequences or death. Factitious hyp...

    Authors: Marina Yukina, Ilana Katsobashvili, Nadezhda Platonova, Ekaterina Troshina and Galina Mel’nichenko
    Citation: Clinical Diabetes and Endocrinology 2022 8:8
  15. Several systemic and sociodemographic factors have been associated with the development and progression of diabetic retinopathy (DR). However, there is limited investigation of the potential role sociodemograp...

    Authors: Chan Tran N. Nguyen, Matheos Yosef, Shokoufeh Khalatbari and Anjali R. Shah
    Citation: Clinical Diabetes and Endocrinology 2022 8:7
  16. Insulin edema is a rare complication which can present after initiation or intensification of insulin therapy in people with diabetes. Initiation of closed-loop hybrid insulin pump therapy can result in rapid ...

    Authors: Mostafa Vasigh and Rachel Hopkins
    Citation: Clinical Diabetes and Endocrinology 2022 8:6
  17. This study aimed to compare the effects of Linagliptin and Empagliflozin on renal function and glycaemic control in patients with type 2 diabetes mellitus (DM).

    Authors: Mohammad Amin Mohammad zadeh Gharabaghi, Mohammad Reza Rezvanfar, Nasser Saeedi, Faezeh Aghajani, Mohammad Alirezaei, Pourya Yarahmadi and Amin Nakhostin-Ansari
    Citation: Clinical Diabetes and Endocrinology 2022 8:5
  18. Many patients with severe COVID-19 have impaired glucose tolerance, and steroid therapy is a standard treatment. Thus, good glycemic control is important and correlates with better patient outcomes. We began u...

    Authors: Yoshihito Takahashi, Hiroshi Matsuura, Hisaya Domi and Hitoshi Yamamura
    Citation: Clinical Diabetes and Endocrinology 2022 8:4
  19. Hyperinsulinemic hypoglycemia is the most common cause of severe and persistent hypoglycemia in neonates and children. It is a heterogeneous condition with dysregulated insulin secretion, which persists in the...

    Authors: M. G. Castillo-López, M. F. Fernandez, N. Sforza, N. C. Barbás, F. Pattin, G. Mendez, F. Ogresta, I. Gondolesi, P. Barros Schelotto, C. Musso and G. E. Gondolesi
    Citation: Clinical Diabetes and Endocrinology 2022 8:3
  20. The prevalence of Gestational Diabetes Mellitus (GDM) varies worldwide among racial and ethnic groups, population characteristics (eg, average age and body mass index (BMI) of pregnant women), testing method, ...

    Authors: Balkachew Nigatu, Tigist Workneh, Thomas Mekuria, Helen Yifter, Yeshiwondim Mamuye and Addisu Gize
    Citation: Clinical Diabetes and Endocrinology 2022 8:2
  21. The increase in growth hormone (GH) secretion during a prolonged fast stimulates lipolytic rate, thereby augmenting the mobilization of endogenous energy at a time when fuel availability is very low.

    Authors: N. Goldenberg, J. F. Horowitz, A. Gorgey, A. Sakharova and A. L. Barkan
    Citation: Clinical Diabetes and Endocrinology 2022 8:1
  22. Individuals with multiple islet autoantibodies are at increased risk for clinical type 1 diabetes and may proceed gradually from stage to stage complicating the recruitment to secondary prevention studies. We ...

    Authors: Maria Månsson Martinez, Lampros Spiliopoulos, Falastin Salami, Daniel Agardh, Jorma Toppari, Åke Lernmark, Jukka Kero, Riitta Veijola, Päivi Tossavainen, Sauli Palmu, Markus Lundgren, Henrik Borg, Anastasia Katsarou, Helena Elding Larsson, Mikael Knip, Marlena Maziarz…
    Citation: Clinical Diabetes and Endocrinology 2022 7:23
  23. Type 2 diabetes reversal has been viewed in the literature primarily as a dichotomous event (reversed or not reversed), even though this viewpoint may not be optimal for clinicians or patients. This cohort stu...

    Authors: Paramesh Shamanna, Shashank Joshi, Lisa Shah, Mala Dharmalingam, Banshi Saboo, Jahangir Mohammed, Maluk Mohamed, Terrence Poon, Nathan Kleinman, Mohamed Thajudeen and Ashok Keshavamurthy
    Citation: Clinical Diabetes and Endocrinology 2021 7:21
  24. Acute kidney injury (AKI) due to Diabetic Ketoacidosis (DKA) is rather common. Novel biomarkers to diagnose AKI are being increasingly used in different settings. The use of urinary Neutrophil Gelatinase-Assoc...

    Authors: Vijai Williams, Muralidharan Jayashree, Karthi Nallasamy, Devi Dayal, Amit Rawat and Savita Verma Attri
    Citation: Clinical Diabetes and Endocrinology 2021 7:20
  25. Gestational diabetes mellitus (GDM) is glucose intolerance first recognised during pregnancy. Both modalities and thresholds of the GDM diagnostic test, the Oral Glucose Tolerance Test (OGTT), have varied wide...

    Authors: Daria Di Filippo, Thiyasha Wanniarachchi, Daniel Wei, Jennifer J. Yang, Aoife Mc Sweeney, Alys Havard, Amanda Henry and Alec Welsh
    Citation: Clinical Diabetes and Endocrinology 2021 7:19
  26. Patients with lipodystrophy are at high risk for chronic complications of diabetes. Recently, we have reported 18 diabetic foot ulcer episodes in 9 subjects with lipodystrophy. This current study aims to deter...

    Authors: O Saydam, B Ozgen Saydam, SC Adiyaman, M Sonmez Ince, MA Eren, FE Keskin, H Bilen, M Dagdeviren, S Kaya, G Akinci, A Balci, C Altay, F Bayraktar, EA Oral and B Akinci
    Citation: Clinical Diabetes and Endocrinology 2021 7:18
  27. There is conflicting evidence regarding an association between gonadotropin releasing hormone analogue (GnRHa) therapy and polycystic ovary syndrome (PCOS). This study aimed to compare the prevalence of endocr...

    Authors: Gilad Karavani, Henry H. Chill, Natali Schachter-Safrai, Gan Lomnitz, David Gillis and Dvora Bauman
    Citation: Clinical Diabetes and Endocrinology 2021 7:14
  28. The study characterizes safety, tolerability, pharmacokinetic and pharmacodynamic profiles of single rising doses of the 11beta-hydroxysteroid dehydrogenase-1 (11beta-HSD1) inhibitor BI 187004 in healthy men w...

    Authors: Susanna Bianzano, Tim Heise, Arvid Jungnik, Cornelia Schepers, Corinna Schölch and Ulrike Gräfe-Mody
    Citation: Clinical Diabetes and Endocrinology 2021 7:16
  29. Diabetic ketoacidosis (DKA) is an emergency with high morbidity and mortality. This study examined patient factors associated with hospitalization for recurrent DKA.

    Authors: Ryan Lyerla, Brianna Johnson-Rabbett, Almoutaz Shakally, Rekha Magar, Hind Alameddine and Lisa Fish
    Citation: Clinical Diabetes and Endocrinology 2021 7:13
  30. Diabetic retinopathy is the most frequent complication of Diabetes Mellitus and remains the leading cause of preventable blindness. However, there are limited studies on the determinants of diabetic retinopath...

    Authors: Kalid Seid, Temamen Tesfaye, Admasu Belay and Hayat Mohammed
    Citation: Clinical Diabetes and Endocrinology 2021 7:12
  31. Hyperglycemia is the most common side-effect of phosphatidylinositol 3-kinase (PI3K) inhibitors that are approved for the treatment of some advanced or metastatic breast cancers. This side-effect is likely due...

    Authors: Nicolas Sahakian, Lauranne Cattieuw, Clotilde Ramillon-Cury, Audrey Bégu-Le Corroller, Pascale Silvestre-Aillaud, Sophie Béliard and René Valéro
    Citation: Clinical Diabetes and Endocrinology 2021 7:17
  32. The relationship between H. pylori infection and obesity development has remained controversial among various studies. The aim of this study was to clarify the pooled effect of H. pylori infection on the devel...

    Authors: Ali Baradaran, Hojat Dehghanbanadaki, Sara Naderpour, Leila Mohammadi Pirkashani, Abdolhalim Rajabi, Roya Rashti, Sevda Riahifar and Yousef Moradi
    Citation: Clinical Diabetes and Endocrinology 2021 7:15
  33. Central Diabetes Insipidus (CDI) results from decreased production of antidiuretic hormone (ADH) leading to an inability to concentrate urine. CDI is treated with desmopressin (DDAVP). Rarely reported in the l...

    Authors: Teresa E. Pinto, Arati Mokashi and Elizabeth A. Cummings
    Citation: Clinical Diabetes and Endocrinology 2021 7:11
  34. High Performance Liquid Chromatography (HPLC) technique is considered as a gold standard for HbA1c analysis however all laboratories cannot adopt it due to certain limitations. Our aim was to compare Particle ...

    Authors: Shabnam Dildar, Sheharbano Imran and Farah Naz
    Citation: Clinical Diabetes and Endocrinology 2021 7:10
  35. With the onset of the COVID-19 pandemic and state-mandated school closures in the spring of 2020, the management of type 1 diabetes in children underwent significant changes. The aim of our study was to assess...

    Authors: Miriannette Gayoso, Whei Ying Lim, Madhuri S. Mulekar and Anne-Marie D. Kaulfers
    Citation: Clinical Diabetes and Endocrinology 2021 7:9
  36. Severe insulin resistance is an uncommon finding in patients with type 2 diabetes but is often associated with difficult to managing blood glucose. While severe insulin resistance is most frequently seen in th...

    Authors: Alison H. Affinati, Amisha Wallia and Roma Y. Gianchandani
    Citation: Clinical Diabetes and Endocrinology 2021 7:8
  37. Gestational Diabetes Mellitus (GDM) is associated with adverse health outcomes during pregnancy and beyond. Previous randomized controlled trials of exercise interventions have demonstrated that exercise, cond...

    Authors: Oluwafemifola Onaade, Jill M. Maples, Bethany Rand, Kimberly B. Fortner, Nikki B. Zite and Samantha F. Ehrlich
    Citation: Clinical Diabetes and Endocrinology 2021 7:7
  38. Hypopituitarism in the elderly population is an underdiagnosed condition and may increase comorbidities related to glucose metabolism, dyslipidemia, and cardiovascular risk factors. Optimization of hormone rep...

    Authors: Isabella Naves Rosa, Alexandre Anderson de Sousa Munhoz Soares, Marcelo Palmeira Rodrigues and Luciana Ansaneli Naves
    Citation: Clinical Diabetes and Endocrinology 2021 7:6
  39. The link between metabolic syndrome and depression has always been controversial. Different studies that have examined the relationship between metabolic syndrome and depression have reported different results...

    Authors: Yousef Moradi, Ahmed N Albatineh, Hassan Mahmoodi and Reza Ghanei Gheshlagh
    Citation: Clinical Diabetes and Endocrinology 2021 7:4
  40. The COVID-19 pandemic has rapidly changed the landscape of medical care and the healthcare system needs to quickly adapt in order to continue providing optimal medical care to hospitalized patients in an effic...

    Authors: Marcio L. Griebeler, Kevin M. Pantalone, Ron Gambino, David Shewmon, Jay Morrow, Daniel Mendlovic, Vinni Makin, Marwan Hamaty, Sana Hasan, M. Cecilia Lansang, Keren Zhou and Bartolome Burguera
    Citation: Clinical Diabetes and Endocrinology 2021 7:5
  41. Type 2 Diabetes is a metabolic disorder characterized by hyperglycemia that causes numerous complications with significant long-term morbidity and mortality. The disorder is primarily due to insulin resistance...

    Authors: Michael Albosta and Jesse Bakke
    Citation: Clinical Diabetes and Endocrinology 2021 7:3
  42. We intended to estimate the proportion hypoglycemic/hyperglycemic emergency episodes in treated diabetes mellitus (DM) patients admitted to a hospital ward, and calculate the prevalence of risk factors for hyp...

    Authors: Sílvia Alão, João Conceição, Jorge Dores, Lèlita Santos, Francisco Araújo, Estevão Pape, Mónica Reis, Árcia Chipepo, Edite Nascimento, Ana Baptista, Vanessa Pires, Carlos Marques, Adriana De Sousa Lages, João Pelicano-Romano and Paula M. de Jesus
    Citation: Clinical Diabetes and Endocrinology 2021 7:2
  43. Evidence suggests that insulin therapy of patients with type 2 diabetes mellitus (T2DM) is frequently discontinued. However, the reasons for discontinuing insulin and factors associated with insulin discontinu...

    Authors: Jianmin Wu, Fritha Morrison, Zhenxiang Zhao, Ginger Haynes, Xuanyao He, Ayad K. Ali, Maria Shubina, Shervin Malmasi, Wendong Ge, Xiaomei Peng and Alexander Turchin
    Citation: Clinical Diabetes and Endocrinology 2021 7:1
  44. The COVID-19 pandemic has prompted the rapid transition of in-person outpatient care to telemedicine, and clinical training to remote learning. The endocrinology fellows at the University of Michigan maintain ...

    Authors: Xin He, Daniel Shelden, Andrew Kraftson, Tobias Else and Richard J. Auchus
    Citation: Clinical Diabetes and Endocrinology 2020 6:25
  45. Acromegaly is associated with higher morbidity and mortality mainly due to cardiovascular disease. Data on the incidence and evolution of thyroid cancer in acromegaly are controversial. Our objective was to de...

    Authors: Karina Danilowicz, Soledad Sosa, Mariana Soledad Gonzalez Pernas, Elizabeth Bamberger, Sabrina Mara Diez, Patricia Fainstein-Day, Alejandra Furioso, Mariela Glerean, Mirtha Guitelman, Débora Katz, Nicole Lemaitre, Alicia Lowenstein, Mariela del Valle Luna, María Paz Martínez, Karina Miragaya, Daniel Moncet…
    Citation: Clinical Diabetes and Endocrinology 2020 6:24
  46. Central pontine myelinolysis (CPM) is a non-inflammatory demyelinating lesion of the pons. CPM and extrapontine demyelination (EPM) are together termed osmotic demyelination syndrome (ODS), a known and serious...

    Authors: Koshi Kusumoto, Nobuyuki Koriyama, Nami Kojima, Maki Ikeda and Yoshihiko Nishio
    Citation: Clinical Diabetes and Endocrinology 2020 6:23

 

Clinical Diabetes and Endocrinology is published in collaboration with the University of Michigan. Authors affiliated with the University of Michigan receive a 15% discount on APC costs.

Annual Journal Metrics

  • 2022 Speed
    21 days submission to first editorial decision for all manuscripts (Median)
    200 days submission to accept (Median)

    2022 Usage 
    299,135 downloads
    578 Altmetric mentions